Orphan Drugs Market 2015-2019

2015-11-11
Price :
Published : Nov-2015
No. of Pages : 108

An orphan drug is used to treat rare diseases or disorders. According to WHO, orphan or rare diseases are the pathological conditions that affect 0.65-1 out of 10,000 population worldwide. There are around 6,000 orphan diseases, of which 80% are genetic. Orphan drugs are developed by the pharmaceutical industry to serve the public health need. These are designated as “Orphan Designations” by the regulatory agencies to accelerate the approval process.

The analysts forecast global orphan drugs market to grow at a CAGR of 10.05% over the period 2014-2019.

Covered in this report

The report covers the current scenario and the growth prospects of the global orphan drugs market for the period of 2015-2019. To calculate the market size, the report considers revenue generated from the sales orphan drugs.

The report, Global Orphan Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and Europe; it also covers the landscape of the global orphan drugs market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key regions

  • Americas
  • APAC
  • Europe

Key vendors

  • Bristol-Mayer Squibb
  • Celgene
  • F. Hoffmann La Roche
  • Novartis
  • Pfizer

Other prominent vendors

  • AbbVie
  • Actelion Pharmaceuticals
  • Alexion Pharmaceuticals
  • Alnylam Pharmaceuticals
  • Amgen
  • AstraZeneca
  • Baxter International
  • Biogen Idec
  • Celldex Therapeutics
  • Eisai
  • Eli Lilly
  • GlaxoSmithKline
  • Intercept Pharmaceuticals
  • Johnson & Johnson
  • Merck
  • NewLink Genetics
  • Northwest Biotherapeutics
  • Novo Nordisk
  • Onyx Pharmaceuticals
  • Sanofi
  • Shire
  • Synageva BioPharma
  • Takeda
  • Vertex Pharmaceuticals
  • XOMA

Market driver

  • Shorter development timelines
  • For a full, detailed list, view our report

Market challenge

  • High cost of drug development
  • For a full, detailed list, view our report

Market trend

  • Increased focus on biological drugs
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Pharmaceutical
Publisher : Technavio
More Reports
Title Price Buy Now

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q4 2016

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2016 Summary GlobalData's "Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2016", report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in Q4 2016. The report portrays detailed comparative data on the number of deals and their value in the last five quarters, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides informati......
$1500

PharmSource – CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance – 2017 Edition

PharmSource - CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition Summary PharmSource's data-rich Trend Report, CMO Scorecard: Outsourcing of NDA Approvals and CMO Performance - 2017 Edition, has ascertained that 2016 was not a halcyon year for new drug approvals with only 25 NMEs being approved since 2010. Global bio/pharma companies received 22 approvals in 2016 (24% of all NDAs), 10% below their 2011-2015 average. Small commercial companies were responsible for 21 approvals (23% of the total), some 5% above their five-year average. There was a clear difference between outsourcing propensity of NME and Non-NME drugs. Only 13% of NMEs sponsored by global bio/pharma comĀ¬panies were outsourced compared with an average of 28% from 2011-2015. However, the larges......
$2995

Global Bone Cement Mixer Devices Market 2017-2021

About Bone Cement Mixer Devices liquid (accelerator) to fill the space between prosthesis and bone deformities. Many new advanced bone cement mixing devices are being developed to decrease the amount of bubble formation and reduce fumes during mixing. The global bone cement mixer devices market is likely to grow at a CAGR of 4.11% during the forecast period. The use of bone cement in interventional procedures such as vertebroplasty and kyphoplasty is on the rise, which will aid the market growth. Increasing prevalence of orthopedic disorders and growing number of orthopedic surgeries also contribute to the market growth. The Americas comprised the majority share of the market in 2016, but APAC is expected to grow at a higher rate during the forecast period. The analysts forecast global......
$3500

Global Micro Guide Catheters Market 2017-2021

About Micro Guide Catheters A micro guide catheter (also known as microcatheter) is a very small single lumen device used on a guidewire to track or help a physician to target a lesion or to cross the lesion. The microcatheter gives mechanical support to the guidewire and enhances its ability to transmit force (pushability and trackability) to the occlusion. The analysts forecast global micro guide catheters market to grow at a CAGR of 8.75% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global micro guide catheters market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of micro guide catheters. The market is divided into the following segments ba......
$3500

Global Surgical Waste Management Market 2017-2021

About Surgical Waste Management Waste that is generated during surgical processes is known as surgical waste. Surgical waste is both hazardous and non-hazardous. Out of the waste generated from surgeries, 85% is non-hazardous and 15% is hazardous. Surgical waste is a huge threat to the environment. Hence, it necessitates proper disposal. Annually, around 250 million surgeries are carried out across the globe, which results in the bulk generation of surgical waste. On average, annually, more than two million tons of surgical waste is being generated. Each day, 5,500 tons of surgical waste is being generated, out of which, approximately 825 tons is hazardous surgical waste. Injections and syringes constitute the bulk of medical waste. Globally, each year, more than 12 billion injections are......
$3500

Global Upper Extremities Market 2017-2021

About Upper Extremities The term "extremity" is generally used to refer to a person's limbs and related parts. Upper extremities include the shoulders, hands, elbows, forearms, wrists, and fingers. Lower extremities consist of the feet, toes, ankles, knees, shins, and thighs. The extremity products are used to treat, repair, replace, or heal extremity injuries such as fractures or damage. These products include external recovery braces, surgical implants, joint replacements, biologics, and external support implants. The analysts forecast global upper extremities market to grow at a CAGR of 6.84% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global upper extremities market for 2017-2021. To calculate the......
$3500

Global Dental Consumables Market 2017-2021

About Dental Consumables Dental consumables are a set of different dental products that are used in individuals to treat dental impairments, for tooth restoration, and in the treatment of associated gingival tissues. Dental consumables are a set of different dental products that are used in dental procedures. Dental implants are the commonly used dental consumables in the tooth restoration procedures. The major causes of tooth loss are tooth decay, gingivitis, injuries, congenital defects, root canal failure, and excessive wear and tear. Osseointegration is a popular procedure adopted by dentists to lock the implant directly into the jawbone. Dental implants are available in different colors and can be customized. The analysts forecast global dental consumables market to grow at a CAGR......
$3500

Global Chiropractic Care Market 2017-2021

About Chiropractic Care Chiropractic is based on the manipulative treatment of joints, spinal column, and musculoskeletal system. It is concerned with the diagnosis, prevention, and treatment of mechanical disorders of the musculoskeletal system. It is based on the manipulative treatment of joints, spinal column, and musculoskeletal system. It is concerned with the diagnosis, prevention, and treatment of mechanical disorders of the musculoskeletal system. The analysts forecast global chiropractic care market to grow at a CAGR of 3.67% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global chiropractic care market for 2017-2021. To calculate the market size, the report considers the revenue generated from ......
$3500

Global Angiography Catheters Market 2017-2021

About Angiography Catheters To treat cardiac diseases such as CAD, physicians perform angiography, which requires catheterization to provide diagnostic and therapeutic treatments. Most of the cardiac catheterization procedures involve access through the femoral and radial arteries. Cardiac catheterization through the femoral artery is a traditional procedure, and is preferred by many physicians. However, many physicians are shifting toward radial artery-based catheterization access as traditional procedures have many complications that can even cause death in certain cases. An angioplasty procedure can be performed by widening the narrow blood vessel (plaqued blood vessel). To view and perform the angioplasty procedure, various types of angiography catheters are used. The analysts fore......
$3500

Adrenal Insufficiency Global Clinical Trials Review, H1, 2017

Adrenal Insufficiency Global Clinical Trials Review, H1, 2017 Summary GlobalData's clinical trial report, "Adrenal Insufficiency Global Clinical Trials Review, H1, 2017" provides an overview of Adrenal Insufficiency clinical trials scenario. This report provides top line data relating to the clinical trials on Adrenal Insufficiency. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Cl......
$2500